To promote the appropriate use of antimicrobials, reduce antimicrobial resistance, and spread of infection caused by multi-drug-resistant organisms and reduce the spread of infection, with the goal of promoting improved patient outcomes in both inpatient and outpatient settings.
To be a national leader in pediatric antimicrobial stewardship by advancing diagnostic excellence, promoting health equity, and supporting responsible antimicrobial prescribing across inpatient, outpatient, and global care settings.
Guidelines for Initial Therapy for Common Pediatric Infections (updated 9/2025)
Drug-Susceptible Tuberculosis Therapy Guideline (PDF) (updated 6/2025)
Pre-Incision Antibiotics for Cesarean Delivery Algorithm (updated 2/2025)
LPCH Blue Card – Antibiogram and Antimicrobial Dosing Quick Reference Card (updated 2/2025)
Inpatient Antibiogram (updated 2/2025)
Amoxicillin-clavulanate (Augmentin®) Dosing Guide (PDF) (updated 1/2025)
Apr 2024 | Stanford Medicine Children’s Health ASP Program again recognized by IDSA Center of Excellence |
Jan 2024 | Stanford Medicine Children’s Health ASP program again recognized by CDPH HAI Antimicrobial Stewardship Honor Roll and designated with GOLD status |
Jul 2023 | Welcome Lauren Kushner, MD, new associate medical director for ASP |
Jul 2022 | ASP Website Launch |
Nov 2021 | Offering of PGY2 Pediatric Infectious Diseases Residency |
May 2021 | Global Changes to Vancomycin Reaction |
All content and media on the Pediatric Antimicrobial Stewardship Program's website is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice.
Connect with us:
Download our App: